Alere says it rejected Abbott's request to end merger deal

April 28 (Reuters) - Diagnostic test maker Alere Inc said its board has rejected a recent request by Abbott Laboratories Inc to terminate the $5.8 billion deal to buy Alere for a breakup fee.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.